摘要
目的探讨羟考酮控释片在治疗肺癌癌痛中的疗效及安全性。方法将我院2009年1月～2012年3月收治的90例肺癌癌痛的患者分为观察组和对照组,对照组采用羟考酮控释片治疗,观察组在对照组的基础上采用甲强龙治疗,比较两组的治疗效果及不良反应。结果观察组与对照组的缓解率分别为86.7%、91.1%,两组比较差异无统计学意义(P>0.05)。但观察组的不良反应显著少于对照组(P<0.05)。结论羟考酮控释片治疗肺癌癌痛疗效较好,若联合甲强龙可降低不良反应出现。
Objective To explore the effect and safety of the testosterone test oxycodone controlled release tablet in the tre^atment of chronic lung cancer. Methods A total of 90 cases of chronic lung cancer from January 2009 to March 2012 were devided into the observation group and control group, and the control group oxycodone controlled release tablet test for treatment, the observation group in the control group on the basis of methylprednisolone treatment, compared the two groups on therapeutic effect and adverse reaction. Results The observation group and the control group remission rates were 86.7%, 91.1%, and there were no statistically significant（P 〉 0.05）. But the observation group adverse reaction of sig- nificant less than the control group （P 〈 0.05）. Conclusion Oxycodone controlled release tablet test in treatment of chronic lung cancer is good curative effect, if methylprednisolone joint can reduce adverse reactions occur.
出处
《中国现代医生》
2012年第29期153-154,共2页
China Modern Doctor
关键词
羟考酮控释片
肺癌
癌痛
安全性
Oxycodone controlled release tablet
Lung cancer
Pain
Safety
